Temperature‐Feedback Nanoplatform for NIR‐II Penta‐Modal Imaging‐Guided Synergistic Photothermal Therapy and CAR‐NK Immunotherapy of Lung Cancer. Issue 43 (23rd June 2021)

• Record Type: Journal Article
• Authors: Xu, Mengze; Xue, Bin; Wang, Yue; Wang, Dan; Gao, Duyang; Yang, Shuo; Zhao, Qi; Zhou, Cangtao; Ruan, Shuangchen; Yuan, Zhen
• Is Part Of: Small. Volume 17:Issue 43(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-23
• Subjects: CAR‐NK -- multimodal imaging -- photothermal therapy -- temperature‐feedback -- the second near‐infrared window; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.202101397
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract: In this study, to visually acquire all‐round structural and functional information of lung cancer while performing synergistic photothermal therapy (PTT) and tumor‐targeting immunotherapy, a theranostic nanoplatform that introduced upconversion nanoparticles (UCNPs) and IR‐1048 dye into the lipid‐aptamer nanostructrure (UCILA) is constructed. Interestingly, the IR‐1048 dye grafted into the lipid bilayer can serve as the theranostic agent for photoacoustic imaging, optical coherence tomography angiography, photothermal imaging, and PTT in the second near infrared (NIR‐II) window. In addition, loaded in the inner part of UCILA, UCNPs possess the superior luminescence property and high X‐ray attenuation coefficient, which can act as contrast agents for computed tomography (CT) and thermo‐sensitive up‐conversion luminescence (UCL) imaging, enabling real‐time tracking of metabolic activity of tumor and temperature‐feedback PTT. Furthermore, under the complementary guidance of penta‐modal imaging and an accurate monitoring of in situ temperature change during PTT, UCILA exhibits its excellent capability for ablating the lung tumor with minimal side effects. Meanwhile, synergistic CAR‐NK immunotherapy is carried out specifically to eradicate any possible residual tumor cells after PTT. Therefore, the UCILA nanoplatform is demonstrated as a multifunctional theranostic agent for both penta‐modal imaging and temperature‐feedback PTT while conducting targeting immunotherapy of lung cancer. Abstract : Effectively temperature‐monitored second near‐infrared (NIR‐II) window photothermal therapy is achieved by a tailored nanoplatform. The nanoplatform also evokes distinguishing imaging capabilities locating in the NIR‐II window. Thus, under the complementary guidance of penta‐modal imaging, this nanoplatform mediates precise NIR‐II photothermal therapy together with targeting chimeric‐antigen‐receptor‐modified natural killer immunotherapy efficiently eradicate the nonsmall‐cell lung carcinoma.